NCT00330798 - A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions

Photorefractive Keratectomy

Interventions

DRUG

nepafenac 0.1%

Nepafenac 0.1% randomly assigned to one eye, with ketorolac 0.4% in the fellow eye for contralateral post-surgical use.

OTHER

ketorolac 0.4%

Keterolac 0.4% randomly assigned to one eye, with nepafenac 0.1% in the fellow eye for contralateral post-surgical use.

Trial Locations (1)

Lackland Air Force Base, San Antonio